The GIV-SP, TC-GKL (msn 1492), became active on January 1, 2025, flying between Istanbul Atatürk and Edremit. The ...

Patriot has unleashed its new Viper Xtreme 5 CKD Non-RGB DRAM: designed for gamers and performance users, with speeds of up ...

AccurKardia has gained the US Food and Drug Administration's (FDA) breakthrough device designation for its AI-powered ‘AK+ ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

BMW Group Malaysia has introduced the 2025 MINI Countryman S All4 to the Malaysian market in locally assembled (CKD) guise, ...

Proton’s expansion plans to the two largest automotive markets in Southeast Asia have hit a snag. Following the Thailand ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

Smoking increases the likelihood of developing numerous morbidities; however, it remains unclear how this behavior may impact ...

Porsche model to be launched in Malaysia is the facelifted Cayenne S E-Hybrid Coupe, which retails for RM728,000 inclusive of ...

The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

Dialysis patients on denosumab (Prolia, Xgeva) had a lower risk for fracture but higher risk for a certain heart event, ...